dbacp02957
General Description
Peptide name : Figainin 2BN
Source/Organism : Norepinephrine-stimulated skin secretion, the Giant Gladiator Treefrog, the Rusty Treefrog, Trinidad, South America
Linear/Cyclic : Linear
Chirality : Not found
Sequence Information
Sequence : FLGVALKLGKVLGKALLPLASSLLHSQ
Peptide length: 27
C-terminal modification: Linear
N-terminal modification : Amidation
Non-natural peptide information: None
Activity Information
Assay type : Not specified
Assay time : Not found
Activity : LC50 : 7-14 µM
Cell line : HT-29
Cancer type : Colon adenocarcinoma
Other activity : Not found
Physicochemical Properties
Amino acid composition bar chart :
Molecular mass : 2774.3896 Dalton
Aliphatic index : 1.625
Instability index : 15.3074
Hydrophobicity (GRAVY) : 1.0074
Isoelectric point : 10.302
Charge (pH 7) : 2.8443
Aromaticity : 0.037
Molar extinction coefficient (cysteine, cystine): (0, 0)
Hydrophobic/hydrophilic ratio : 2.375
hydrophobic moment : 0.8885
Missing amino acid : C,R,W,T,M,I,E,D,Y,N
Most occurring amino acid : L
Most occurring amino acid frequency : 9
Least occurring amino acid : F
Least occurring amino acid frequency : 1
Structural Information
3D structure :
Secondary structure fraction (Helix, Turn, Sheet): (0.5, 0.2, 0.4)
SMILES Notation: CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
Secondary Structure :
| Method | Prediction |
|---|---|
| GOR | HHHHHHHHHHEHTCEECHHHHEEEETT |
| Chou-Fasman (CF) | EEEHHHHEEEEHHHHHHCCCCCCCCCC |
| Neural Network (NN) | HHHHHHHHHHHHHHHHHHHHHHHHHCC |
| Joint/Consensus | HHHHHHHHHHCHHHHHHHHHHCCCCCC |
Molecular Descriptors and ADMET Properties
Molecular Descriptors: Click here to download
ADMET Properties: Click here to download
Cross Referencing databases
CancerPPD : Not available
ApIAPDB : Not available
CancerPPD2 ID : Not available
Reference
1 : Conlon JM, et al. Purification, Conformational Analysis and Cytotoxic Activities of Host-Defense Peptides from the Giant Gladiator Treefrog Boana boans (Hylidae: Hylinae). Antibiotics (Basel). 2023; 12:(unknown pages). doi: 10.3390/antibiotics12071102
Literature
Paper title : Purification, Conformational Analysis and Cytotoxic Activities of Host-Defense Peptides from the Giant Gladiator Treefrog Boana boans (Hylidae: Hylinae).
Doi : https://doi.org/10.3390/antibiotics12071102
Abstract : Frogs from the extensive amphibian family Hylidae are a rich source of peptides with therapeutic potential. Peptidomic analysis of norepinephrine-stimulated skin secretions from the Giant Gladiator Treefrog Boana boans (Hylidae: Hylinae) collected in Trinidad led to the isolation and structural characterization of five host-defense peptides with limited structural similarity to figainin 2 and picturin peptides from other frog species belonging to the genus Boana. In addition, the skin secretions contained high concentrations of tryptophyllin-BN (WRPFPFL) in both C-terminally α-amidated and non-amidated forms. Figainin 2BN (FLGVALKLGKVLG KALLPLASSLLHSQ) and picturin 1BN (GIFKDTLKKVVAAVLTTVADNIHPK) adopt α-helical conformations in trifluroethanol-water mixtures and in the presence of cell membrane models (sodium dodecylsulfate and dodecylphosphocholine micelles). The CD data also indicate contributions from turn structures. Both peptides and picturin 2BN (GLMDMLKKVGKVALT VAKSALLP) inhibited the growth of clinically relevant Gram-negative and Gram-positive bacteria with MIC values in the range 7.8-62.5 µM. Figainin 2BN was potently cytotoxic to A549, MDA-MB-231 and HT-29 human tumor-derived cells (LC<sub>50</sub> = 7-14 µM) but displayed comparable potency against non-neoplastic HUVEC cells (LC<sub>50</sub> = 15 µM) indicative of lack of selectivity for cancer cells.